genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Coronavirus
COVID-19 Puts Spotlight on Artificial Intelligence
Industry News
VAST Ambition When It Comes To Data Storage
Antisense
NeuBase Sets a Course for the Clinic
Bioprocessing
Cytiva Picks Up Where GE Leaves Off after $21B Deal
Industry News
Putting COVID-19 on the ‘Map’
News
Infectious Diseases
New Recombineering Method May Overcome Key Obstacle in Genetically Engineering Bacteria
Drug Discovery
Cocaine Cravings Curbed Dramatically in Mice Treated Using New Small Molecule
Genetics
On PAR: How X and Y Chromosomes Recombine During Meiosis
Diabetes
Electrogenetic Device Allows Remote Control of Cell Signaling
Cancer
Brain Tumor Immune Microenvironment Profiled
Insights
All
Trends for 2020
Bioprocessing
COVID-19 Will Have Long Lasting Impact on Biopharma Manufacturing
Bioprocessing
Decreasing the Time from Antibody Idea to IND Approval
Bioprocessing
Introducing New Bioprocessing Technologies in the Era of COVID-19
Bioprocessing
Smart AI Use Could Benefit Biopharma
A-Lists
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Industry News
Catching Up to Coronavirus: Top 60 Treatments in Development
Industry News
Top 15 Best-Selling Drugs of 2019
Industry News
How to Conquer Coronavirus: Top 35 Treatments in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Infectious Diseases
New Recombineering Method May Overcome Key Obstacle in Genetically Engineering Bacteria
Drug Discovery
Cocaine Cravings Curbed Dramatically in Mice Treated Using New Small Molecule
Diabetes
Electrogenetic Device Allows Remote Control of Cell Signaling
Cancer
Brain Tumor Immune Microenvironment Profiled
Magazine
All
Supplement
Coronavirus
Race for a Coronavirus Vaccine
Drug Discovery
Protein Modulation Helps Drug Design Get a Grip
OMICs
Proteomic Mass Spec Assesses Biomolecular Teamwork
Coronavirus
COVID-19 Drives CRISPR Diagnostics
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
On Demand Webinars
Organoids and Spheroids Help Science See in 3D
Upcoming Webinars
A CRISPR Vision for the Future of Cell Therapy
Upcoming Webinars
Looking toward the Future of Cell & Gene Therapies
Upcoming Webinars
DNA as Medicine: Encoding Cancer Therapeutic Antibodies
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Industry News
Industry News
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Industry News
Axcan to Buy Mpex for Phase III-Stage Aerosol Antibiotic
Industry News
Amgen Targets Brazil Through $215M Takeover of Bergamo and Reacquisition of Products
Industry News
Acorda Axing 25% of Workforce, Slashing R&D Spending
Industry News
GEN Survey on Brexit and Biotech
Industry News
FDA Places Holds on Three Seattle Genetics Trials Following Four Patient Deaths
Industry News
Biopharma Investment Grows During Q4 but VCs Fund Fewer Early Deals
Industry News
Venter Relinquishes CEO Role as HLI Steps Up Commercial Activity
Industry News
Merrimack Halts Development of Pancreatic Cancer Candidate After Phase II Failure
Industry News
Tarveda Therapeutics Completes $30M Series D Financing
Industry News
Catabasis Raises $14.5M to Progress Preclinical Antidiabetic
Industry News
MedImmune to Develop Compugen Immuno-Oncology Antibodies
Industry News
Novo Nordisk Eliminating 1,000 Jobs Worldwide
Industry News
MAP Secures $60M Equity Financing as Migraine Drug Moves Closer to...
Industry News
Amgen Expands China Presence, Cancer R&D with $2.7B BeiGene Collaboration
Industry News
Alnylam Losses Widened by Tekmira Settlement
1
2
3
...
362
Page 1 of 362
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Merrimack Pharmaceuticals is ending development of its pancreatic cancer candidate MM-141 (istiratumab) following its failure in a Phase II trial. [NIH]](https://www.genengnews.com/wp-content/uploads/2018/08/Mar16_2017_NIH_PancreaticCancerCells1501202401-324x160.jpg "Merrimack Halts Development of Pancreatic Cancer Candidate After Phase II Failure")
